New hope for nerve disease patients: blood-filtering therapy tested in 140-person study

NCT ID NCT07154524

First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 36 times

Summary

This study looks at whether a blood-filtering procedure called immunoadsorption (IA) can safely and effectively help people with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disorder that causes weakness and numbness. About 140 adults who are already on standard treatments (IVIg or steroids) but are not improving will be switched to IA and followed for 18 months. The goal is to see if IA can better control the disease when other treatments fail.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Ulm

    RECRUITING

    Ulm, Baden-Wurttemberg, 89081, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.